Bafna Pharmaceuticals is currently trading at Rs. 27.70, up by 0.95 points or 3.55% from its previous closing of Rs. 26.75 on the BSE.
The scrip opened at Rs. 27.70 and has touched a high and low of Rs. 28.35 and Rs. 26.90 respectively. So far 44887 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 38.50 on 02-Jul-2014 and a 52 week low of Rs. 16.90 on 01-Apr-2014.
Last one week high and low of the scrip stood at Rs. 29.00 and Rs. 24.10 respectively. The current market cap of the company is Rs. 51.86 crore.
The promoters holding in the company stood at 36.95% while Non-Institutions held 63.05% stake in the company.
Bafna Pharmaceuticals has successfully cleared the renewal of audit process as per the guidelines issued by the Medicine and Healthcare Product Agency (MHRA- UK) for European Union GMP.
Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.
